Regulation of Actinomycin D induced upregulation of Mdm2 in H1299 cells

DNA Repair

Volumn 11, Issue 2, 2012, Pages 112-119

  Li, Lianjie ^a   Cui, Di ^a   Zheng, Shijun J ^a   Lou, Huiqiang ^a   Tang, Jun ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Actinomycin d; Mdm2; NEDDylation; Ribosomal stress

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOHEXIMIDE; DACTINOMYCIN; DOXORUBICIN; PROTEIN MDM2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN STABILITY; SIGNAL TRANSDUCTION; STRESS; UBIQUITINATION; UPREGULATION;

CELL DEATH; CELL LINE; CELL PROLIFERATION; DACTINOMYCIN; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINS; UP-REGULATION;

EID: 84855837785     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2011.10.010     Document Type: Article

References (38)

1. Manfredi J.J. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev. 2010, 24:1580-1589.
2. Bond G.L., Hu W.W., Levine A.J. MDM2 is a central node in the p53 pathway: 12 years and counting. Curr. Cancer Drug Targets 2005, 5:3-8.
3. Bouska A., Eischen C.M. Murine double minute 2: p53-independent roads lead to genome instability or death. Trends Biochem. Sci. 2009, 34:279-286.
4. Deisenroth C., Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010, 29:4253-4260.
5. Lohrum M.A.E., Ashcroft M., Kubbutat M.H.G., Vousden K.H. Identification of a cryptic nucleolar-localization signal in MDM2. Nat. Cell Biol. 2000, 2:179-181.
6. Momand J., Wu H.H., Dasgupta G. MDM2 - master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29.
7. Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y., Shkedy D. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:14973-14977.
8. Marine J.C., Lozano G. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ. 2010, 17:93-102.
9. Meek D.W. The p53 response to DNA damage. DNA Repair 2004, 3:1049-1056.
10. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
11. Salcedo A., Mayor F., Penela P. Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J. 2006, 25:4752-4762.
12. Hsing A., Faller D.V., Vaziri C. DNA-damaging aryl hydrocarbons induce mdm2 expression via p53-independent post-transcriptional mechanisms. J. Biol. Chem. 2000, 275:26024-26031.
13. Lee J.T., Gu W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 2010, 17:86-92.
14. Xirodimas D.P., Saville M.K., Bourdon J.C., Hay R.T., Lane D.P. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 2004, 118:83-97.
15. Watson I.R., Li B.K., Roche O., Blanch A., Ohh M., Irwin M.S. Chemotherapy induces NEDP1-mediated destabilization of MDM2. Oncogene 2010, 29:297-304.
16. Lai K.P., Leong W.F., Chau J.F.L., Jia D.Y., Zeng L., Liu H.J., He L., Hao A.J., Zhang H.B., Meek D., Velagapudi C., Habib S.L., Li B.J. S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response. EMBO J. 2010, 29:2994-3006.
17. Zhou B.H.P., Liao Y., Xia W.Y., Zou Y.Y., Spohn B., Hung M.C. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 2001, 3:973-982.
18. Sundqvist A., Liu G., Mirsaliotis A., Xirodimas D.P. Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep. 2009, 10:1132-1139.
19. Boisvert F.M., van Koningsbruggen S., Navascues J., Lamond A.I. The multifunctional nucleolus. Nat. Rev. Mol. Cell Bio. 2007, 8:574-585.
20. Zhang Y.P., Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16:369-377.
21. Lohrum M.A.E., Ludwig R.L., Kubbutat M.H.G., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3:577-587.
22. Dai M.S., Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 2004, 279:44475-44482.
23. Dai M.S., Zeng S.X., Jin Y.T., Sun X.X., David L., Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell Biol. 2004, 24:7654-7668.
24. Tang J., Qu L.K., Zhang J., Wang W., Michaelson J.S., Degenhardt Y.Y., El-Deiry W.S., Yang X.O. Critical role for Daxx in regulating Mdm2. Nat. Cell Biol. 2006, 8. 855-U115.
25. Tang J., Qu L.K., Pang M.S., Yang X.L. Daxx is reciprocally regulated by Mdm2 and Hausp. Biochem. Biophys. Res. Commun. 2010, 393:542-545.
26. Xirodimas D., Saville M.K., Edling C., Lane D.P., Lain S. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 2001, 20:4972-4983.
27. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., Babcock G.F., Bernardi R., Pandolfi P.P., Thomas G. Absence of nucleolar disruption after impairment of 40s ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell Biol. 2009, 11. 501-U350.
28. Dornan D., Wertz I., Shimizu H., Arnott D., Frantz G.D., Dowd P., O' Rourke K., Koeppen H., Dixit V.M. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004, 429:86-92.
29. Zeng S.X., Dai M.S., Keller D.M., Lu H. SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J. 2002, 21:5487-5497.
30. Brazil D.P., Park J., Hemmings B.A. PKB binding proteins: getting in on the akt. Cell 2002.
31. Shinozaki T., Nota A., Taya Y., Okamoto K. Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export. Oncogene 2003, 22:8870-8880.
32. Maya R., Balass M., Kim S.T., Shkedy D., Leal J.F., Shifman O., Moas M., Buschmann T., Ronai Z., Shiloh Y., Kastan M.B., Katzir E., Oren M. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev 2001, 15:1067-1077.
33. Goldberg Z., Vogt Sionov R., Berger M., Zwang Y., Perets R., Van Etten R.A., Oren M., Taya Y., Haupt Y. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J. 2002, 21:3715-3727.
34. Waning D.L., Lehman J.A., Batuello C.N., Mayo L.D. c-Abl phosphorylation of Mdm2 facilitates Mdm2-Mdmx complex formation. J. Biol. Chem. 2011, 286:216-222.
35. Nakanishi H., Brewer K.A., Exton J.H. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 1993, 268:13-16.
36. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348.
37. Krammer P.H., Igney F.H. Death anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2002, 2:277-288.
38. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science 1991, 253:49-53.